Coronary angiography with Iopamidol.
Iopamidol, a new non-ionic contrast medium with low osmolality, was compared with Isopaque Coronar during selective coronary angiography in 16 patients. Iopamidol caused significantly less bradycardia, less ECG changes and less fall in blood pressure than Isopaque Coronar. No subjective adverse effects such as chest pain, vomiting, nausea or sensation of heat occurred. The results indicate that Iopamidol has advantages as a contrast medium for coronary angiography.
D000328:Adult; D000368:Aged; D000790:Angiocardiography; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D003287:Contrast Media / Q000009:adverse effects; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007479:Iopamidol; D007483:Iothalamic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D008297:Male; D008794:Metrizoic Acid / Q000009:adverse effects / Q000031:analogs & derivatives; D008875:Middle Aged; D009994:Osmolar Concentration
D003287:Contrast Media; D007483:Iothalamic Acid; D008794:Metrizoic Acid; D007479:Iopamidol; C021342:methylglucamine metrizoate